Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

January 6, 2016

Mark T. Whitford Jr. Elected Partner at Barclay Damon

ROCHESTER, NY "” January 6, 2016 "” Barclay Damon, LLP announces the election of Mark T. Whitford, Jr. to partner.

Mr. Whitford is a member of the Insurance Coverage & Regulatory, Torts & Products Liability Defense and Commercial Litigation practice areas and is resident in the firm's Rochester office. He represents national and regional insurers in litigated coverage disputes arising under professional liability and commercial general liability policies, including extracontractual claims. Mr. Whitford's coverage practice is national in nature including, for example, working on the concussion litigation in California involving former NFL and NCAA players. He represents individuals and businesses in a wide-range of commercial, insurance and tort defense matters, including appeals throughout New York and the Court of Appeals for the Second Circuit.

Prior to joining the firm, Mr. Whitford served as an Appellate Court Attorney at the New York Supreme Court, Appellate Division, Third Judicial Department.

Mr. Whitford received a B.A., summa cum laude, in Political Science from the State University of New York at Buffalo and his J.D., with honors, from the University of Connecticut School of Law.

Barclay Damon, LLP, listed as a "Top 250 Firm" by The National Law Journal, is a full-service, 275-attorney law firm, with offices throughout the major cities of New York State; Toronto; and Boston, Washington DC, and Newark. Barclay Damon provides comprehensive legal and business counsel to a diverse client base in 33 practice areas. For more information, visit barclaydamon.com.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Second Circuit Reverses Award of Attorney's Fees in Coverage Dispute Between Liability Insurers

Alerts

Federal Court Narrows Scope of Insurers' Privilege Claims in COVID-19 Coverage Litigation

Alerts

AstraZeneca Escalates FARXIGA® Audit Demands: What Pharmacies Need to Know Now

Alerts

Update on the Evolving Guidance for H-1B Entry Restrictions Under September 19 Presidential Proclamation

Alerts

Attention Providers! OMIG Audit Update: New Settlement Flexibility at Lower Confidence Payment Restored and DME Protocol Released

Alerts

NYS Trial Court Holds: Animals Are Family Too